Bioxcel Therapeutics Inc (BTAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Operating Expenses | 21,098 | 24,768 | 21,435 | 14,996 | 8,413 |
| Operating Income | -21,098 | -24,768 | -21,435 | -14,996 | -8,413 |
| Interest Expense | 4 | 5 | 12 | 6 | 2 |
| Other Income | 16 | 20 | 28 | 91 | 140 |
| Pre-tax Income | -21,086 | -24,753 | -21,419 | -14,911 | -8,275 |
| Net Income Continuous | -21,086 | -24,753 | -21,419 | -14,911 | -8,275 |
| Net Income | $-21,086 | $-24,753 | $-21,419 | $-14,911 | $-8,275 |
| EPS Basic Total Ops | -13.92 | -17.12 | -16.96 | -12.64 | -7.20 |
| EPS Basic Continuous Ops | -13.99 | -17.18 | -16.89 | -12.58 | -7.21 |
| EPS Diluted Total Ops | -13.92 | -17.12 | -16.96 | -12.64 | -7.20 |
| EPS Diluted Continuous Ops | -13.99 | -17.18 | -16.89 | -12.58 | -7.21 |
| EBITDA(a) | $-21,053 | $-24,720 | $-21,387 | $-14,949 | $-8,475 |